Kemper 10-Q Details $460M Goodwill Impairment Behind Q3 Turnaround
KMPR sits 46% above its 52-week low of $22.69.
Summary
Kemper's Q3 10-Q confirms the $52.4 million profit already reported, but reveals a $460.0 million goodwill impairment that drove a $414.1 million nine-month loss and shows the underlying P&C combined ratio deteriorating to 101.7%.
Key Events · Earnings and Guidance · KMPR
-
Q3 Profit Confirmed at $52.4M
Net income of $52.4 million, or $0.88 per diluted share, versus a $21.0 million loss a year ago; adjusted consolidated net operating income was $59.9 million ($1.01 per share) versus $20.4 million.
-
$460M Goodwill Impairment Drives 9M Loss
A non-cash $460.0 million goodwill impairment in Specialty P&C recorded in Q2 2026 pushed the nine-month net loss to $414.1 million ($7.04 per share) versus $151.3 million of income a year ago.
-
Underlying P&C Margins Deteriorate
Specialty P&C underlying combined ratio worsened to 101.7% in Q3 from 99.6%, and to 103.3% for nine months from 95.2%, on California bodily injury severity and a $40.0 million Florida Statutory Profit Limit Refund.
-
Credit Agreement Covenants Tightened
An August 3, 2026 amendment replaced the consolidated net worth covenant with a tangible net worth covenant and added quarterly risk-based capital tests for Trinity and United Insurance; capacity was cut to $350 million on May 4, 2026.
Analysis · KMPR · Finance
The headline Q3 numbers were already out this morning, but the full 10-Q fills in the story: a $460.0 million non-cash goodwill impairment in Specialty P&C booked in Q2 2026 explains why the nine-month result is a $414.1 million net loss ($7.04 per share) despite Q3 net income of $52.4 million. The quarter's profit leaned heavily on $23.2 million of favorable prior-year reserve development versus $51.4 million adverse a year ago, while the underlying combined ratio worsened to 101.7% from 99.6% on California bodily injury severity. Nine-month adjusted operating income of $98.7 million is less than half last year's $210.9 million. The filing also shows the credit agreement was tightened in August 2026 — a tangible net worth covenant plus new risk-based capital tests for two insurance subsidiaries — and that buybacks have stopped, with $304.2 million left on the authorization.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KMPR was trading at $33.15 on NYSE in the Finance sector, with a market capitalization of approximately $2B. The 52-week trading range was $22.69 to $41.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.